Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model.

about

Meropenem-vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria.Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections

P2860

Q52564980-978626A5-9B42-4F42-975C-E24A5172F667 Q58733616-ED1E6845-B004-4DD6-AE05-215A832B28FE

P2860

Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model.

Item

http://www.wikidata.org/entity/Q47604376

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Activity of Simulated Human Do ...... n In Vitro Hollow-Fiber Model.

@en

Activity of Simulated Human Do ...... n In Vitro Hollow-Fiber Model.

@nl

type

Item

label

Activity of Simulated Human Do ...... n In Vitro Hollow-Fiber Model.

@en

Activity of Simulated Human Do ...... n In Vitro Hollow-Fiber Model.

@nl

prefLabel

Activity of Simulated Human Do ...... n In Vitro Hollow-Fiber Model.

@en

Activity of Simulated Human Do ...... n In Vitro Hollow-Fiber Model.

@nl

P1476

Activity of Simulated Human Do ...... an In Vitro Hollow-Fiber Model

@en

P2093

David C Griffith

http://www.w3.org/2001/XMLSchema#string

Debora Rubio-Aparicio

http://www.w3.org/2001/XMLSchema#string

Jonathan Parkinson

http://www.w3.org/2001/XMLSchema#string

Michael N Dudley

http://www.w3.org/2001/XMLSchema#string

Olga Lomovskaya

http://www.w3.org/2001/XMLSchema#string

Thomas G Nolan

http://www.w3.org/2001/XMLSchema#string

Ziad Tarazi

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases

Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae

Carbapenem resistance in Enterobacteriaceae: here is the storm!

Carbapenem-resistant enterobacteriaceae: an emerging problem in children.

The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the β-Lactamase Inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects

Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates

Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies.

Global spread of Carbapenemase-producing Enterobacteriaceae

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

P31

scholarly article

P356

10.1128/AAC.01969-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mojgan Sabet

P577

2018-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29133570

http://www.w3.org/2001/XMLSchema#string

P921

carbapenem antibiotic

P932

5786802

http://www.w3.org/2001/XMLSchema#string

Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model.

about

P2860

P2860

Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932